speb/financial-data huggingface dataset:
HCAT balance_sheet (annual, 2025-12-31) — Current Liabilities: 89573000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 89573000.00
HCAT cash_flow (annual, 2025-12-31) — Deferred Income Tax: 81000.00
HCAT cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 195000.00
HCAT cash_flow (annual, 2025-12-31) — Deferred Tax: 81000.00
HCAT cash_flow (quarterly, 2025-12-31) — Deferred Tax: 195000.00
HCAT cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 50500000.00
HCAT cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 12882000.00
HCAT income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 50500000.00
HCAT income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 12882000.00
HCAT cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 50500000.00
HCAT cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 12882000.00
HCAT income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 50500000.00
HCAT income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 12882000.00
HCAT income_statement (annual, 2025-12-31) — Diluted Average Shares: 69896000.00
HCAT income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 70998000.00
HCAT income_statement (annual, 2025-12-31) — Diluted EPS: -2.55
HCAT income_statement (quarterly, 2025-12-31) — Diluted EPS: -1.28
HCAT income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -177974000.00
HCAT income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -91025000.00
HCAT income_statement (annual, 2025-12-31) — EBIT: -153004000.00
HCAT income_statement (quarterly, 2025-12-31) — EBIT: -85129000.00
HCAT income_statement (annual, 2025-12-31) — EBITDA: -102504000.00
HCAT income_statement (quarterly, 2025-12-31) — EBITDA: -72247000.00
HCAT cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 27000.00
HCAT cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 22000.00
HCAT cash_flow (annual, 2025-12-31) — End Cash Position: 50814000.00
HCAT cash_flow (quarterly, 2025-12-31) — End Cash Position: 50814000.00
HCAT cash_flow (annual, 2025-12-31) — Financing Cash Flow: -235782000.00
HCAT cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -434000.00
HCAT cash_flow (annual, 2025-12-31) — Free Cash Flow: -20822000.00
HCAT cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 4316000.00
HCAT balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 1586000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 1586000.00
HCAT income_statement (annual, 2025-12-31) — General And Administrative Expense: 44598000.00
HCAT income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 6083000.00
HCAT balance_sheet (annual, 2025-12-31) — Goodwill: 209073000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Goodwill: 209073000.00
HCAT balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 286751000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 286751000.00
HCAT balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 62828000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 62828000.00
HCAT balance_sheet (annual, 2025-12-31) — Gross PPE: 93804000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Gross PPE: 93804000.00
HCAT income_statement (annual, 2025-12-31) — Gross Profit: 151675000.00
HCAT income_statement (quarterly, 2025-12-31) — Gross Profit: 39383000.00
HCAT income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 110223000.00
HCAT income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 81454000.00
HCAT income_statement (annual, 2025-12-31) — Interest Expense: 24254000.00
HCAT income_statement (quarterly, 2025-12-31) — Interest Expense: 5517000.00
HCAT income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 24254000.00
HCAT income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 5517000.00
HCAT income_statement (annual, 2025-12-31) — Interest Income: 7535000.00
HCAT income_statement (quarterly, 2025-12-31) — Interest Income: 909000.00
HCAT income_statement (annual, 2025-12-31) — Interest Income Non Operating: 7535000.00
HCAT income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 909000.00
HCAT cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 21949000.00
HCAT balance_sheet (annual, 2025-12-31) — Interest Payable: 3380000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Interest Payable: 3380000.00
HCAT balance_sheet (annual, 2025-12-31) — Invested Capital: 399031000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Invested Capital: 399031000.00
HCAT cash_flow (annual, 2025-12-31) — Investing Cash Flow: 36193000.00
HCAT cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 1009000.00
HCAT cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
HCAT cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
HCAT balance_sheet (annual, 2025-12-31) — Leases: 6314000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Leases: 6314000.00
HCAT balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 14208000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 14208000.00
HCAT balance_sheet (annual, 2025-12-31) — Long Term Debt: 151624000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 151624000.00
HCAT balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 165832000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 165832000.00
HCAT cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
HCAT cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
HCAT cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -232292000.00
HCAT cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -407000.00
HCAT balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 80850000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 80850000.00
HCAT cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -41114000.00
HCAT cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
HCAT cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -5000000.00
HCAT cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
HCAT balance_sheet (annual, 2025-12-31) — Net Debt: 102437000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Net Debt: 102437000.00
HCAT income_statement (annual, 2025-12-31) — Net Income: -177974000.00
HCAT income_statement (quarterly, 2025-12-31) — Net Income: -91025000.00
HCAT income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -177974000.00
HCAT income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -91025000.00
HCAT income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -177974000.00
HCAT income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -91025000.00
HCAT income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -177974000.00
HCAT income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -91025000.00
HCAT income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -177974000.00
HCAT income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -91025000.00
HCAT cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -177974000.00
HCAT cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -91025000.00
HCAT income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -177974000.00
HCAT income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -91025000.00
HCAT cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -805000.00
HCAT cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -181000.00
HCAT income_statement (annual, 2025-12-31) — Net Interest Income: -16719000.00
HCAT income_statement (quarterly, 2025-12-31) — Net Interest Income: -4608000.00
HCAT cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 98816000.00
HCAT cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 6592000.00
HCAT cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -232292000.00
HCAT cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -407000.00
HCAT cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -232292000.00
HCAT cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -407000.00
HCAT income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -16719000.00
HCAT income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -4608000.00
HCAT balance_sheet (annual, 2025-12-31) — Net PPE: 40478000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Net PPE: 40478000.00
HCAT cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -924000.00
HCAT cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -260000.00
HCAT balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -40971000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -40971000.00
HCAT balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 410000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 410000.00
HCAT balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 410000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 410000.00
HCAT income_statement (annual, 2025-12-31) — Normalized EBITDA: 15606000.00
HCAT income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 17094000.00
HCAT income_statement (annual, 2025-12-31) — Normalized Income: -84667100.00
HCAT income_statement (quarterly, 2025-12-31) — Normalized Income: -20445610.00
HCAT cash_flow (annual, 2025-12-31) — Operating Cash Flow: 731000.00
HCAT cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 9912000.00
HCAT income_statement (annual, 2025-12-31) — Operating Income: -42744000.00
HCAT income_statement (quarterly, 2025-12-31) — Operating Income: 3261000.00
HCAT income_statement (annual, 2025-12-31) — Operating Revenue: 311136000.00
HCAT income_statement (quarterly, 2025-12-31) — Operating Revenue: 74679000.00
HCAT balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 72027332.00
HCAT balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 72027332.00
HCAT balance_sheet (annual, 2025-12-31) — Other Current Assets: 14447000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 14447000.00
HCAT balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 1627000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 1627000.00
HCAT balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 1586000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 1586000.00
HCAT income_statement (annual, 2025-12-31) — Other Gand A: 44598000.00
HCAT income_statement (quarterly, 2025-12-31) — Other Gand A: 6083000.00
HCAT income_statement (annual, 2025-12-31) — Other Income Expense: -117795000.00
HCAT income_statement (quarterly, 2025-12-31) — Other Income Expense: -89300000.00
HCAT balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 77678000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 77678000.00
HCAT cash_flow (annual, 2025-12-31) — Other Non Cash Items: -837000.00
HCAT cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 1499000.00
HCAT balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 6107000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 6107000.00
HCAT balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 1048000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 1048000.00
HCAT income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 315000.00
HCAT income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 41000.00
HCAT balance_sheet (annual, 2025-12-31) — Other Properties: 6640000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Other Properties: 6640000.00
HCAT balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 44918000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 44918000.00
HCAT income_statement (annual, 2025-12-31) — Other Special Charges: 6900000.00
HCAT balance_sheet (annual, 2025-12-31) — Payables: 9363000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Payables: 9363000.00
HCAT balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 22857000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 22857000.00
HCAT balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 5203000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 5203000.00
HCAT balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
HCAT balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
HCAT income_statement (annual, 2025-12-31) — Pretax Income: -177258000.00
HCAT income_statement (quarterly, 2025-12-31) — Pretax Income: -90646000.00
HCAT cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 1510000.00
HCAT cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: -27000.00
HCAT balance_sheet (annual, 2025-12-31) — Properties: 0.00
HCAT balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
HCAT cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 1503000.00
HCAT cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 93000.00
HCAT cash_flow (annual, 2025-12-31) — Purchase Of Business: -41114000.00
HCAT cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
HCAT cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -805000.00
HCAT cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -181000.00
HCAT cash_flow (annual, 2025-12-31) — Purchase Of Investment: -65132000.00
HCAT cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -7908000.00
HCAT cash_flow (annual, 2025-12-31) — Purchase Of PPE: -968000.00
HCAT cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -273000.00
HCAT balance_sheet (annual, 2025-12-31) — Receivables: 59128000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Receivables: 59128000.00
HCAT income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 159461000.00
HCAT income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 35296000.00
HCAT income_statement (annual, 2025-12-31) — Reconciled Depreciation: 50500000.00
HCAT income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 12882000.00
HCAT cash_flow (annual, 2025-12-31) — Repayment Of Debt: -232292000.00
HCAT cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -407000.00
HCAT cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -5000000.00
HCAT cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
HCAT income_statement (annual, 2025-12-31) — Research And Development: 49770000.00
HCAT income_statement (quarterly, 2025-12-31) — Research And Development: 9911000.00
HCAT income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 987000.00
HCAT balance_sheet (annual, 2025-12-31) — Retained Earnings: -1364646000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -1364646000.00
HCAT cash_flow (annual, 2025-12-31) — Sale Of Investment: 163948000.00
HCAT cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 14500000.00
HCAT cash_flow (annual, 2025-12-31) — Sale Of PPE: 44000.00
HCAT cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 13000.00
HCAT income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 49551000.00
HCAT income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 7246000.00
HCAT income_statement (annual, 2025-12-31) — Selling General And Administration: 94149000.00
HCAT income_statement (quarterly, 2025-12-31) — Selling General And Administration: 13329000.00
HCAT balance_sheet (annual, 2025-12-31) — Share Issued: 72027332.00
HCAT balance_sheet (quarterly, 2025-12-31) — Share Issued: 72027332.00
HCAT income_statement (annual, 2025-12-31) — Special Income Charges: -118110000.00
HCAT income_statement (quarterly, 2025-12-31) — Special Income Charges: -89341000.00
HCAT cash_flow (annual, 2025-12-31) — Stock Based Compensation: 27012000.00
HCAT cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 4107000.00
HCAT balance_sheet (annual, 2025-12-31) — Stockholders Equity: 245780000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 245780000.00
HCAT balance_sheet (annual, 2025-12-31) — Tangible Book Value: -40971000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -40971000.00
HCAT income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -24803100.00
HCAT income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -18761610.00
HCAT income_statement (annual, 2025-12-31) — Tax Provision: 716000.00
HCAT income_statement (quarterly, 2025-12-31) — Tax Provision: 379000.00
HCAT income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
HCAT income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
HCAT balance_sheet (annual, 2025-12-31) — Total Assets: 502643000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Total Assets: 502643000.00
HCAT balance_sheet (annual, 2025-12-31) — Total Capitalization: 397404000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 397404000.00
HCAT balance_sheet (annual, 2025-12-31) — Total Debt: 171238000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Total Debt: 171238000.00
HCAT balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 245780000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 245780000.00
HCAT income_statement (annual, 2025-12-31) — Total Expenses: 353880000.00
HCAT income_statement (quarterly, 2025-12-31) — Total Expenses: 71418000.00
HCAT balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 256863000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 256863000.00
HCAT balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 333336000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 333336000.00
HCAT balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 167290000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 167290000.00
HCAT income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -160854000.00
HCAT income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -86080000.00
HCAT income_statement (annual, 2025-12-31) — Total Unusual Items: -118110000.00
HCAT income_statement (quarterly, 2025-12-31) — Total Unusual Items: -89341000.00
HCAT income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -118110000.00
HCAT income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -89341000.00
HCAT balance_sheet (annual, 2025-12-31) — Working Capital: 79734000.00
HCAT balance_sheet (quarterly, 2025-12-31) — Working Capital: 79734000.00
HCAT income_statement (quarterly, 2026-03-31) — +Operating Expense: 42626000.00
HCAT income_statement (quarterly, 2026-03-31) — +Total Revenue: 70756000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 11694000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 59146000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -56913000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -4200000.00
HCAT cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: -227000.00
HCAT cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 95501000.00
HCAT income_statement (quarterly, 2026-03-31) — Basic Average Shares: 72593210.00
HCAT income_statement (quarterly, 2026-03-31) — Basic EPS: -1.53
HCAT cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 50814000.00
HCAT cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -5495000.00
HCAT cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -4604000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 17213000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1612808000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 59864000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 108823000.00
HCAT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -4000.00
HCAT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -9406000.00
HCAT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 18511000.00
HCAT cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 4407000.00
HCAT cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -943000.00
HCAT cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 13452000.00
HCAT cash_flow (quarterly, 2026-03-31) — Change In Payable: 4407000.00
HCAT cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 4407000.00
HCAT cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -33000.00
HCAT cash_flow (quarterly, 2026-03-31) — Change In Receivables: -591000.00
HCAT cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 16292000.00
HCAT cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -591000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Common Stock: 1612808000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 138145000.00
HCAT cash_flow (quarterly, 2026-03-31) — Common Stock Payments: 0.00
HCAT income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 35293000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 15848000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Current Assets: 182312000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 3731000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Current Debt: 1627000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 5358000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 69736000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 69736000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 107613000.00
HCAT cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 44000.00
HCAT cash_flow (quarterly, 2026-03-31) — Deferred Tax: 44000.00
HCAT cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 12115000.00
HCAT income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 12115000.00
HCAT cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 12115000.00
HCAT income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 12115000.00
HCAT income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 72593210.00
HCAT income_statement (quarterly, 2026-03-31) — Diluted EPS: -1.53
HCAT income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -111026000.00
HCAT income_statement (quarterly, 2026-03-31) — EBIT: -105870000.00
HCAT income_statement (quarterly, 2026-03-31) — EBITDA: -93755000.00
HCAT cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -51000.00
HCAT cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -4000.00
HCAT cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 13016000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 1009000.00
HCAT income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 10259000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Goodwill: 113251000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 182583000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 63346000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Gross PPE: 98103000.00
HCAT income_statement (quarterly, 2026-03-31) — Gross Profit: 35463000.00
HCAT income_statement (quarterly, 2026-03-31) — Impairment Of Capital Assets: 95501000.00
HCAT income_statement (quarterly, 2026-03-31) — Interest Expense: 4742000.00
HCAT income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 4742000.00
HCAT income_statement (quarterly, 2026-03-31) — Interest Income: 798000.00
HCAT income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 798000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Interest Payable: 3211000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Invested Capital: 291510000.00
HCAT cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -9406000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Leases: 6312000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 13482000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 151738000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 165220000.00
HCAT cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -407000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 85536000.00
HCAT cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 0.00
HCAT cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
HCAT balance_sheet (quarterly, 2026-03-31) — Net Debt: 93501000.00
HCAT income_statement (quarterly, 2026-03-31) — Net Income: -111026000.00
HCAT income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -111026000.00
HCAT income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -111026000.00
HCAT income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -111026000.00
HCAT income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -111026000.00
HCAT cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -111026000.00
HCAT income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -111026000.00
HCAT cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -553000.00
HCAT income_statement (quarterly, 2026-03-31) — Net Interest Income: -3944000.00
HCAT cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -3915000.00
HCAT cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -407000.00
HCAT cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -407000.00
HCAT income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -3944000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Net PPE: 41190000.00
HCAT cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -334000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -44438000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 227000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 227000.00
HCAT income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 5559000.00
HCAT income_statement (quarterly, 2026-03-31) — Normalized Income: -51437600.00
HCAT cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 18511000.00
HCAT income_statement (quarterly, 2026-03-31) — Operating Income: -7163000.00
HCAT income_statement (quarterly, 2026-03-31) — Operating Revenue: 70756000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 73748666.00
HCAT balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 14343000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 1627000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 1009000.00
HCAT income_statement (quarterly, 2026-03-31) — Other Gand A: 10259000.00
HCAT income_statement (quarterly, 2026-03-31) — Other Income Expense: -99505000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 69332000.00
HCAT cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 1487000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 6117000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 997000.00
HCAT income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -191000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Other Properties: 6255000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 48959000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Payables: 11694000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 27542000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 4977000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
HCAT income_statement (quarterly, 2026-03-31) — Pretax Income: -110612000.00
HCAT cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 403000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
HCAT cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 555000.00
HCAT cash_flow (quarterly, 2026-03-31) — Purchase Of Business: 0.00
HCAT cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -553000.00
HCAT cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -24915000.00
HCAT cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -338000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Receivables: 59146000.00
HCAT income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 35293000.00
HCAT income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 12115000.00
HCAT cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -407000.00
HCAT cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: 0.00
HCAT income_statement (quarterly, 2026-03-31) — Research And Development: 9779000.00
HCAT income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 3813000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -1475672000.00
HCAT cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 21000000.00
HCAT cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 4000.00
HCAT income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 10473000.00
HCAT income_statement (quarterly, 2026-03-31) — Selling General And Administration: 20732000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Share Issued: 73748666.00
HCAT income_statement (quarterly, 2026-03-31) — Special Income Charges: -99314000.00
HCAT cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 3770000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 138145000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -44438000.00
HCAT income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -39725600.00
HCAT income_statement (quarterly, 2026-03-31) — Tax Provision: 414000.00
HCAT income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
HCAT balance_sheet (quarterly, 2026-03-31) — Total Assets: 412202000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 289883000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Total Debt: 170578000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 138145000.00
HCAT income_statement (quarterly, 2026-03-31) — Total Expenses: 77919000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 274057000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 229890000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 166444000.00
HCAT income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -106477000.00
HCAT income_statement (quarterly, 2026-03-31) — Total Unusual Items: -99314000.00
HCAT income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -99314000.00
HCAT balance_sheet (quarterly, 2026-03-31) — Working Capital: 74699000.00
HCC cash_flow (annual, 2021-12-31) — Common Stock Payments: 0.00
HCC income_statement (annual, 2021-12-31) — Depreciation Amortization Depletion Income Statement: 141418000.00
HCC cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: 1595000.00
HCC balance_sheet (annual, 2021-12-31) — Hedging Assets Current: 4043000.00
HCC cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 0.00
HCC cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: -40000000.00
HCC balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 1842000.00
HCC income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: 1291000.00
HCC cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
HCC cash_flow (annual, 2021-12-31) — Purchase Of Investment: 0.00
HCC cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: 0.00
HCC cash_flow (annual, 2021-12-31) — Sale Of Business: 0.00
HCC cash_flow (annual, 2021-12-31) — Sale Of Investment: 0.00
HCC cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 0.00
HCC cash_flow (annual, 2021-12-31) — Short Term Debt Payments: -40000000.00
HCC income_statement (annual, 2022-12-31) — +Operating Expense: 48791000.00
HCC income_statement (annual, 2022-12-31) — +Total Revenue: 1738738000.00
HCC balance_sheet (annual, 2022-12-31) — Accounts Payable: 39026000.00
HCC balance_sheet (annual, 2022-12-31) — Accounts Receivable: 151826000.00
HCC balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -681187000.00
HCC balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 269956000.00
HCC income_statement (annual, 2022-12-31) — Basic Average Shares: 51622000.00
HCC income_statement (annual, 2022-12-31) — Basic EPS: 12.42
HCC cash_flow (annual, 2022-12-31) — Beginning Cash Position: 395839000.00
HCC balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 81737000.00
HCC cash_flow (annual, 2022-12-31) — Capital Expenditure: -208742000.00
HCC balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 33091000.00
HCC balance_sheet (annual, 2022-12-31) — Capital Stock: 539000.00
HCC balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 829480000.00
HCC balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 838088000.00
HCC cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -79665000.00
HCC cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -153119000.00
HCC cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -255144000.00
HCC cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 841904000.00
HCC cash_flow (annual, 2022-12-31) — Change In Account Payable: -5442000.00
HCC cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 22803000.00
HCC cash_flow (annual, 2022-12-31) — Change In Inventory: -79845000.00
HCC cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 798000.00
HCC cash_flow (annual, 2022-12-31) — Change In Payable: -5442000.00
HCC cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 17361000.00
HCC cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 888000.00
HCC cash_flow (annual, 2022-12-31) — Change In Receivables: -22451000.00
HCC cash_flow (annual, 2022-12-31) — Change In Working Capital: -83249000.00
HCC cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -29676000.00
HCC cash_flow (annual, 2022-12-31) — Changes In Cash: 433641000.00
HCC balance_sheet (annual, 2022-12-31) — Common Stock: 539000.00
HCC cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -79665000.00
HCC balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1447515000.00
HCC balance_sheet (annual, 2022-12-31) — Construction In Progress: 168025000.00
HCC income_statement (annual, 2022-12-31) — Cost Of Revenue: 852931000.00
HCC balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 76434000.00
HCC balance_sheet (annual, 2022-12-31) — Current Assets: 1173109000.00
HCC balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 24089000.00
HCC balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 24089000.00
HCC balance_sheet (annual, 2022-12-31) — Current Deferred Assets: 18952000.00
HCC balance_sheet (annual, 2022-12-31) — Current Liabilities: 153124000.00
HCC balance_sheet (annual, 2022-12-31) — Current Provisions: 3900000.00
HCC cash_flow (annual, 2022-12-31) — Deferred Income Tax: 141806000.00
HCC cash_flow (annual, 2022-12-31) — Deferred Tax: 141806000.00
HCC cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 115279000.00
HCC income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 115279000.00
HCC income_statement (annual, 2022-12-31) — Diluted Average Shares: 51715000.00
HCC income_statement (annual, 2022-12-31) — Diluted EPS: 12.40
HCC income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 641298000.00
HCC income_statement (annual, 2022-12-31) — EBIT: 814537000.00
HCC income_statement (annual, 2022-12-31) — EBITDA: 929816000.00
HCC balance_sheet (annual, 2022-12-31) — Employee Benefits: 27407000.00
HCC cash_flow (annual, 2022-12-31) — End Cash Position: 829480000.00
HCC cash_flow (annual, 2022-12-31) — Financing Cash Flow: -153119000.00
HCC balance_sheet (annual, 2022-12-31) — Finished Goods: 109822000.00
HCC cash_flow (annual, 2022-12-31) — Free Cash Flow: 633162000.00
HCC cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 4043000.00
HCC balance_sheet (annual, 2022-12-31) — Gross PPE: 1508770000.00
HCC income_statement (annual, 2022-12-31) — Gross Profit: 885807000.00
HCC balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 0.00
HCC cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 0.00
HCC income_statement (annual, 2022-12-31) — Interest Expense: 31433000.00
HCC income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 31433000.00
HCC income_statement (annual, 2022-12-31) — Interest Income: 12438000.00
HCC income_statement (annual, 2022-12-31) — Interest Income Non Operating: 12438000.00
HCC cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 27810000.00
HCC balance_sheet (annual, 2022-12-31) — Interest Payable: 2038000.00
HCC balance_sheet (annual, 2022-12-31) — Inventory: 154039000.00
HCC balance_sheet (annual, 2022-12-31) — Invested Capital: 1750103000.00
HCC cash_flow (annual, 2022-12-31) — Investing Cash Flow: -255144000.00
HCC cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
HCC balance_sheet (annual, 2022-12-31) — Land And Improvements: 90776000.00
HCC balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 9002000.00
HCC balance_sheet (annual, 2022-12-31) — Long Term Debt: 302588000.00
HCC balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 311590000.00
HCC cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
HCC cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -69730000.00
HCC balance_sheet (annual, 2022-12-31) — Long Term Provisions: 64581000.00
HCC balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 852141000.00
HCC cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 2533000.00
HCC income_statement (annual, 2022-12-31) — Net Income: 641298000.00
HCC income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 641298000.00
HCC income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 641298000.00
HCC income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 641298000.00
HCC income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 641298000.00
HCC cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 641298000.00
HCC income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 641298000.00
HCC income_statement (annual, 2022-12-31) — Net Interest Income: -18995000.00
HCC cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 0.00
HCC cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -69730000.00
HCC cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -69730000.00
HCC income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -18995000.00
HCC cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -3724000.00
HCC cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -48935000.00
HCC balance_sheet (annual, 2022-12-31) — Net PPE: 827583000.00
HCC cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -208742000.00
HCC balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 1447515000.00
HCC balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 7572000.00
HCC balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 23378000.00
HCC balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 7572000.00
HCC balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 23378000.00
HCC balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 7087000.00
HCC income_statement (annual, 2022-12-31) — Normalized EBITDA: 965408000.00
HCC income_statement (annual, 2022-12-31) — Normalized Income: 670447848.00
HCC cash_flow (annual, 2022-12-31) — Operating Cash Flow: 841904000.00
HCC cash_flow (annual, 2022-12-31) — Operating Gains Losses: 4043000.00
HCC income_statement (annual, 2022-12-31) — Operating Income: 837016000.00
HCC income_statement (annual, 2022-12-31) — Operating Revenue: 1707579000.00
HCC balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 51653568.00
HCC balance_sheet (annual, 2022-12-31) — Other Current Assets: 5143000.00
HCC balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 8674000.00
HCC income_statement (annual, 2022-12-31) — Other Income Expense: -34917000.00
HCC cash_flow (annual, 2022-12-31) — Other Non Cash Items: 5106000.00
HCC balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 12744000.00
HCC balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 500000.00
HCC income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 675000.00
HCC balance_sheet (annual, 2022-12-31) — Other Properties: 97550000.00
HCC balance_sheet (annual, 2022-12-31) — Other Receivables: 3637000.00
HCC balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 8608000.00
HCC income_statement (annual, 2022-12-31) — Other Special Charges: 35592000.00
HCC balance_sheet (annual, 2022-12-31) — Payables: 40027000.00
HCC balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 116461000.00
HCC balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
HCC balance_sheet (annual, 2022-12-31) — Prepaid Assets: 1424000.00
HCC income_statement (annual, 2022-12-31) — Pretax Income: 783104000.00
HCC cash_flow (annual, 2022-12-31) — Purchase Of Investment: 0.00
HCC cash_flow (annual, 2022-12-31) — Purchase Of PPE: -208742000.00
HCC balance_sheet (annual, 2022-12-31) — Raw Materials: 44217000.00
HCC balance_sheet (annual, 2022-12-31) — Receivables: 155463000.00
HCC income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 852931000.00
HCC income_statement (annual, 2022-12-31) — Reconciled Depreciation: 115279000.00
HCC cash_flow (annual, 2022-12-31) — Repayment Of Debt: -69730000.00
HCC balance_sheet (annual, 2022-12-31) — Retained Earnings: 1227596000.00
HCC cash_flow (annual, 2022-12-31) — Sale Of Business: 2533000.00
HCC cash_flow (annual, 2022-12-31) — Sale Of Investment: 0.00
HCC cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
HCC income_statement (annual, 2022-12-31) — Selling General And Administration: 48791000.00
HCC balance_sheet (annual, 2022-12-31) — Share Issued: 53875409.00
HCC income_statement (annual, 2022-12-31) — Special Income Charges: -35592000.00
HCC cash_flow (annual, 2022-12-31) — Stock Based Compensation: 17621000.00
HCC balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1447515000.00
HCC balance_sheet (annual, 2022-12-31) — Tangible Book Value: 1447515000.00
HCC income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -6442152.00
HCC income_statement (annual, 2022-12-31) — Tax Provision: 141806000.00
HCC income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.18
HCC balance_sheet (annual, 2022-12-31) — Taxes Receivable: 0.00
HCC balance_sheet (annual, 2022-12-31) — Total Assets: 2028095000.00
HCC balance_sheet (annual, 2022-12-31) — Total Capitalization: 1750103000.00
HCC balance_sheet (annual, 2022-12-31) — Total Debt: 335679000.00
HCC balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1447515000.00
HCC income_statement (annual, 2022-12-31) — Total Expenses: 901722000.00
HCC balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 580580000.00
HCC balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 854986000.00
HCC balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 427456000.00
HCC income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 801424000.00
HCC balance_sheet (annual, 2022-12-31) — Total Tax Payable: 1001000.00
HCC income_statement (annual, 2022-12-31) — Total Unusual Items: -35592000.00
HCC income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -35592000.00
HCC balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 2221841.00
HCC balance_sheet (annual, 2022-12-31) — Treasury Stock: 50576000.00
HCC balance_sheet (annual, 2022-12-31) — Working Capital: 1019985000.00
HCC income_statement (annual, 2023-12-31) — +Operating Expense: 51817000.00
HCC income_statement (annual, 2023-12-31) — +Total Revenue: 1676625000.00
HCC balance_sheet (annual, 2023-12-31) — Accounts Payable: 36245000.00
HCC balance_sheet (annual, 2023-12-31) — Accounts Receivable: 98225000.00
HCC balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -793064000.00
HCC balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 279332000.00
HCC income_statement (annual, 2023-12-31) — Basic Average Shares: 51973000.00
HCC income_statement (annual, 2023-12-31) — Basic EPS: 9.21
HCC cash_flow (annual, 2023-12-31) — Beginning Cash Position: 829480000.00
HCC balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 38223000.00
HCC cash_flow (annual, 2023-12-31) — Capital Expenditure: -491674000.00
HCC balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 20219000.00
HCC balance_sheet (annual, 2023-12-31) — Capital Stock: 542000.00
HCC balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 738197000.00
HCC balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 747227000.00
HCC cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -61077000.00
HCC cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -265184000.00
HCC cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -527207000.00
HCC cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 701108000.00
HCC cash_flow (annual, 2023-12-31) — Change In Account Payable: 215000.00
HCC cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -8645000.00
HCC cash_flow (annual, 2023-12-31) — Change In Inventory: -30785000.00
HCC cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 11000.00
HCC cash_flow (annual, 2023-12-31) — Change In Payable: 215000.00
HCC cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -8430000.00
HCC cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -2034000.00
HCC cash_flow (annual, 2023-12-31) — Change In Receivables: 46955000.00
HCC cash_flow (annual, 2023-12-31) — Change In Working Capital: 5717000.00
HCC cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 53601000.00
HCC cash_flow (annual, 2023-12-31) — Changes In Cash: -91283000.00
HCC balance_sheet (annual, 2023-12-31) — Common Stock: 542000.00